Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.

Delma FZ, Al-Hatmi AMS, Buil JB, van der Lee H, Tehupeiory-Kooreman M, de Hoog GS, Meletiadis J, Verweij PE.

Antimicrob Agents Chemother. 2020 Mar 24;64(4). pii: e02261-19. doi: 10.1128/AAC.02261-19. Print 2020 Mar 24.

PMID:
32015025
2.

High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections.

Schauwvlieghe AFAD, Buil JB, Verweij PE, Hoek RAS, Cornelissen JJ, Blijlevens NMA, Henriet SSV, Rijnders BJA, Brüggemann RJM.

Mycoses. 2020 Feb;63(2):122-130. doi: 10.1111/myc.13028. Epub 2019 Dec 15.

3.

External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris.

Buil JB, van der Lee HAL, Curfs-Breuker I, Verweij PE, Meis JF.

J Fungi (Basel). 2019 Oct 7;5(4). pii: E94. doi: 10.3390/jof5040094.

4.

The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus.

Buil JB, Hare RK, Zwaan BJ, Arendrup MC, Melchers WJG, Verweij PE.

PLoS Pathog. 2019 Aug 22;15(8):e1007858. doi: 10.1371/journal.ppat.1007858. eCollection 2019 Aug. No abstract available.

5.

Trends in Azole Resistance in Aspergillus fumigatus, the Netherlands, 1994-2016.

Buil JB, Snelders E, Denardi LB, Melchers WJG, Verweij PE.

Emerg Infect Dis. 2019 Jan;25(1):176-178. doi: 10.3201/eid2501.171925.

6.

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates.

Buil JB, Hagen F, Chowdhary A, Verweij PE, Meis JF.

J Fungi (Basel). 2018 Aug 29;4(3). pii: E103. doi: 10.3390/jof4030103.

7.

Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis.

Abdolrasouli A, Bercusson AC, Rhodes JL, Hagen F, Buil JB, Tang AYY, de Boer LL, Shah A, Milburn AJ, Elborn JS, Jones AL, Meis JF, Fisher MC, Schelenz S, Simmonds NJ, Armstrong-James D.

Mycoses. 2018 Sep;61(9):665-673. doi: 10.1111/myc.12789. Epub 2018 Jun 20.

8.

Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples.

Buil JB, Zoll J, Verweij PE, Melchers WJG.

Front Microbiol. 2018 Mar 21;9:515. doi: 10.3389/fmicb.2018.00515. eCollection 2018. Review.

9.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Buil JB, Brüggemann RJM, Wasmann RE, Zoll J, Meis JF, Melchers WJG, Mouton JW, Verweij PE.

J Antimicrob Chemother. 2018 Jan 1;73(1):263. doi: 10.1093/jac/dkx425. No abstract available.

PMID:
29112717
10.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Buil JB, Brüggemann RJM, Wasmann RE, Zoll J, Meis JF, Melchers WJG, Mouton JW, Verweij PE.

J Antimicrob Chemother. 2018 Jan 1;73(1):134-142. doi: 10.1093/jac/dkx354. Erratum in: J Antimicrob Chemother. 2018 Jan 1;73(1):263.

PMID:
29048485
11.

Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.

Buil JB, van der Lee HAL, Rijs AJMM, Zoll J, Hovestadt JAMF, Melchers WJG, Verweij PE.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01250-17. doi: 10.1128/AAC.01250-17. Print 2017 Dec.

12.

In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.

Buil JB, Rijs AJMM, Meis JF, Birch M, Law D, Melchers WJG, Verweij PE.

J Antimicrob Chemother. 2017 Sep 1;72(9):2548-2552. doi: 10.1093/jac/dkx177.

PMID:
28605488
13.

Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?

Buil JB, Meis JF, Melchers WJ, Verweij PE.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3259-60. doi: 10.1128/AAC.00256-16. Print 2016 May. No abstract available.

Supplemental Content

Support Center